Add this topic to your myFT Digest for news straight to your inbox
Results of UK study show drug cuts symptom duration by about 4 days but does not reduce deaths
Before she steps down this month, the vice-chancellor of Oxford university talks about cancel culture, state schools and why universities should not be businesses
Christ Church racked up a £6.6mn bill for legal and PR fees in a dispute with Martyn Percy
Investors are crowding in on the promise of ‘unlimited clean energy’
Setback for a method hoped to provide better protection against virus transmission
Technology used to develop Covid vaccines may help in the fight against other diseases
Are the sceptics too sceptical?
Having helped create the AstraZeneca Covid-19 drug, the Oxford scientist has another urgent goal, to eliminate malaria through vaccination
Reputation for long-term stability under pressure amid concerns over chief executive’s management style
The industry has yet to demonstrate any real utility, despite the fanfare, billions of VC dollars and three Spacs
Long-term effects are generally less in children, although infection doubles risk of epilepsy
Investors warn that lack of availability is driving some companies to US cities
Oxford Science Enterprises wants to step up funding of companies derived from academic research
Could the prime minister’s fall be a turning point for Britain?
Failure in sport is clear-cut and gets punished, unlike in government
Christ Church issues statement as dispute with Martyn Percy continues despite £1.2mn settlement
Consultants and tech start-ups offer a large share of courses but partnerships can draw on different strengths
Packing up a workspace is a huge task but one Oxford scientist did just that — and his team have now joined him in the Netherlands
From Partygate to Brexit, many of today’s political dramas can be traced back to the leading players’ student days
Oxford university spinout seeks to add to $100mn already raised in drive to succeed where Theranos failed
Puzzle: find the Ukrainian’s winning move
Academics and investors urge greater investment in Oxford-Cambridge Arc innovation hub
Board minded to recommend offer that values UK precision equipment maker at £1.8bn
A lively and enlightening account of how four female Oxonians refuted the zealot thinking of mid-century philosophy
From scholarships and loans to sponsorship and savings, careful research repays the effort
International Edition